Sign Up
bg
A

Agios (AGIO)

$000.00 0.00% ($0.00)

  • Today
  • Week
  • Month
  • Year
  • 5 Year
  • YTD
barakagetbaraka.com

About Agios (AGIO)

Agios Pharmaceuticals, Inc is a clinical-stage biopharmaceutical company. The Company's lead product candidate in its genetically defined disease (GDD) portfolio, mitapivat, is an activator for the treatment of hemolytic anemias. The Company’s clinic... Read more

  • USD28.00
  • USD28.46
  • USD27.30
  • USD46.00
  • 1.90%
  • 45M
  • 77.00
  • 1.46M
  • 1.7B
  • 22.24
  • -19.00%

Stock News